151 results
Page 4 of 8
8-K
EX-10.2
jdqlt91duu2wy55che
3 Oct 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
9r55tj6z1upeuid
3 Oct 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
tfrxaspgpg
23 Apr 13
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.2
due58 18cz9w5
23 Apr 13
Departure of Directors or Certain Officers
12:00am
POS AM
EX-10.56
niji1tmab31 ritu0vmc
27 Apr 12
Prospectus update (post-effective amendment)
12:00am
8-K
EX-10.1
rxzmj3nougnqg12n
11 Jan 12
NeoGenomics Enters Into Exclusive Worldwide Licensing Agreement
12:00am
8-K
EX-10.2
wth8xo2z vl
11 Jan 12
NeoGenomics Enters Into Exclusive Worldwide Licensing Agreement
12:00am
8-K
EX-10.4
95ei1yh0z83ca
11 Jan 12
NeoGenomics Enters Into Exclusive Worldwide Licensing Agreement
12:00am
8-K
EX-10.5
i89gq3sbi syu
11 Jan 12
NeoGenomics Enters Into Exclusive Worldwide Licensing Agreement
12:00am
8-K
EX-10.3
rkmazc
11 Jan 12
NeoGenomics Enters Into Exclusive Worldwide Licensing Agreement
12:00am
8-A12G
EX-10.13
37xkg654rsrk09gox2e4
2 May 11
Registration of securities
12:00am
8-A12G
EX-10.12
15raq7e4107llewoatg
2 May 11
Registration of securities
12:00am
10-Q/A
EX-10.24
edw6lqr3ea9qm7
17 Feb 11
Quarterly report (amended)
12:00am
10-Q/A
EX-10.44
xf2c 2xddq14n
17 Feb 11
Quarterly report (amended)
12:00am
10-Q/A
EX-10.39
wsmvwnl3bqd6t75i31
17 Feb 11
Quarterly report (amended)
12:00am
10-Q/A
EX-10.35
59x14obf1sq m6
17 Feb 11
Quarterly report (amended)
12:00am